Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v4-FR
Language French French
Date Updated 2018-02-05 2018-02-05
Drug Identification Number 02246859 02246859
Brand name APO-FENO-SUPER APO-FENO-SUPER
Common or Proper name FENOFIBRATE FENOFIBRATE
Company Name AA PHARMA INC AA PHARMA INC
Ingredients FENOFIBRATE FENOFIBRATE
Strength(s) 100MG 100MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 BLS 30 BLS
ATC code C10AB C10AB
ATC description LIPID MODIFYING AGENTS, PLAIN LIPID MODIFYING AGENTS, PLAIN
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2017-05-31 2017-05-31
Actual discontinuation date 2017-05-31 2017-05-31
Remaining supply date 2016-12-01 2016-12-01
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments APO-FENO-SUPER FCT 100MG 100 BTL is available APO-FENO-SUPER FCT 100MG 100 BTL is available
Health Canada comments